| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.075 | 0.06 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.07 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.07 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.082 | 0.07 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.07 |